Skip to main content
Top
Published in: BMC Gastroenterology 1/2012

Open Access 01-12-2012 | Research article

A prospective experimental study of liver fibrosis with ultrasound and its correlation with hepatic reserve function and hemodynamics

Authors: Yi-Lin Yang, Li Di, Yun-You Duan, Xi Liu, Jie Liu, Rui-Jing Yang, Sheng Chen, Li-Jun Yuan

Published in: BMC Gastroenterology | Issue 1/2012

Login to get access

Abstract

Background

Progressive hepatic fibrosis is the eventual cause of liver cirrhosis. Doppler ultrasound has been used to detect hemodynamic changes that are known to be present during the pre-cirrhotic stages of hepatic fibrogenesis. However, the relationship between the Doppler ultrasound parameters and the impairment of the liver function has not been fully investigated. The purpose of this study was to explore the hepatic function reserve and its relationship with the hepatic hemodynamics in a rabbit model of liver fibrosis using Doppler ultrasound.

Methods

A prospective study was performed. Sixty healthy New Zealand rabbits were included in this study. Eleven of them served as controls and were normally fed and provided with water drink; the rest of 49 rabbits that served as fibrosis group were normally fed but provided with 1.2 g/L of thioacetamide to create liver fibrosis model. Doppler measurements were performed in the portal trunk, proper hepatic artery and proper splenic artery. The hepatic circulation index (HCI) was calculated. Hepatic function reverse was evaluated by measuring the indocyanine green clearance and retention rate at 15 min (ICG R15) test. Portal venous pressure (PVP) was measured using the portal vein punctuation equipment.

Results

HCI was significantly decreased and PVP increased in the advanced fibrotic stage (F4) compared to mild and moderate fibrotic stage (F1-3), respectively (p<0.05). PVP and ICG R15 in the fibrotic group were significantly higher than that in the control group (ICG: 0.209±0.086 vs. 0.093±0.023, p<0.01). Within the fibrotic groups, PVP was higher in advanced fibrotic stage (F4) than those in mild (F1-2) or moderate (F3) fibrotic stages (p<0.05). Both HCI and PVP correlated well with ICG R15 (r = −0.890, and r = 0.780, p <0.01).

Conclusions

Hepatic function reserve closely relates to the hepatic hemodynamics in the rabbit model of liver fibrosis. Doppler Ultrasound could be reliably used to assess the hepatic function reserve and hemodynamic changes in different stages of liver fibrosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Friedman SL, Bansal MB: Reversal of hepatic fibrosis–fact or fantasy?. Hepatology. 2006, 43 (2 Suppl 1): S82-S88.CrossRefPubMed Friedman SL, Bansal MB: Reversal of hepatic fibrosis–fact or fantasy?. Hepatology. 2006, 43 (2 Suppl 1): S82-S88.CrossRefPubMed
2.
go back to reference Garcea G, Ong SL, Maddern GJ: Predicting liver failure following major hepatectomy. Dig Liver Dis. 2009, 41 (11): 798-806. 10.1016/j.dld.2009.01.015.CrossRefPubMed Garcea G, Ong SL, Maddern GJ: Predicting liver failure following major hepatectomy. Dig Liver Dis. 2009, 41 (11): 798-806. 10.1016/j.dld.2009.01.015.CrossRefPubMed
3.
go back to reference Liguori Carino N, O'Reilly DA, Dajani K, Ghaneh P, Poston GJ, Wu AV: Perioperative use of the LiMON method of indocyanine green elimination measurement for the prediction and early detection of post-hepatectomy liver failure. Eur J Surg Oncol. 2009, 35 (9): 957-962. 10.1016/j.ejso.2009.02.003.CrossRefPubMed Liguori Carino N, O'Reilly DA, Dajani K, Ghaneh P, Poston GJ, Wu AV: Perioperative use of the LiMON method of indocyanine green elimination measurement for the prediction and early detection of post-hepatectomy liver failure. Eur J Surg Oncol. 2009, 35 (9): 957-962. 10.1016/j.ejso.2009.02.003.CrossRefPubMed
4.
go back to reference Villeneuve JP, Huot R, Marleau D, Huet PM: The estimation of hepatic blood flow with indocyanine green: comparison between the continuous infusion and single injection methods. Am J Gastroenterol. 1982, 77 (4): 233-237.PubMed Villeneuve JP, Huot R, Marleau D, Huet PM: The estimation of hepatic blood flow with indocyanine green: comparison between the continuous infusion and single injection methods. Am J Gastroenterol. 1982, 77 (4): 233-237.PubMed
5.
go back to reference Wang P, Chaudry IH: Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am J Physiol. 1996, 270 (5 Pt 2): R927-R938.PubMed Wang P, Chaudry IH: Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am J Physiol. 1996, 270 (5 Pt 2): R927-R938.PubMed
6.
go back to reference Bravo AA, Sheth SG, Chopra S: Liver biopsy. N Engl J Med. 2001, 344 (7): 495-500. 10.1056/NEJM200102153440706.CrossRefPubMed Bravo AA, Sheth SG, Chopra S: Liver biopsy. N Engl J Med. 2001, 344 (7): 495-500. 10.1056/NEJM200102153440706.CrossRefPubMed
7.
go back to reference Bonekamp S, Kamel I, Solga S, Clark J: Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?. J Hepatol. 2009, 50 (1): 17-35.CrossRefPubMed Bonekamp S, Kamel I, Solga S, Clark J: Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?. J Hepatol. 2009, 50 (1): 17-35.CrossRefPubMed
8.
go back to reference Haktanir A, Cihan BS, Celenk C, Cihan S: Value of Doppler sonography in assessing the progression of chronic viral hepatitis and in the diagnosis and grading of cirrhosis. J Ultrasound Med. 2005, 24 (3): 311-321.PubMed Haktanir A, Cihan BS, Celenk C, Cihan S: Value of Doppler sonography in assessing the progression of chronic viral hepatitis and in the diagnosis and grading of cirrhosis. J Ultrasound Med. 2005, 24 (3): 311-321.PubMed
9.
go back to reference Cosar S, Oktar SO, Cosar B, Yücel C, Ozdemir H: Doppler and gray-scale ultrasound evaluation of morphological and hemodynamic changes in liver vascualture in alcoholic patients. Eur J Radiol. 2005, 54 (3): 393-399. 10.1016/j.ejrad.2004.07.015.CrossRefPubMed Cosar S, Oktar SO, Cosar B, Yücel C, Ozdemir H: Doppler and gray-scale ultrasound evaluation of morphological and hemodynamic changes in liver vascualture in alcoholic patients. Eur J Radiol. 2005, 54 (3): 393-399. 10.1016/j.ejrad.2004.07.015.CrossRefPubMed
10.
go back to reference Liu P, Gao YH: Liver fibrosis animal models. World Chin J Digestol. 2002, 10 (6): 693-695. Liu P, Gao YH: Liver fibrosis animal models. World Chin J Digestol. 2002, 10 (6): 693-695.
11.
go back to reference Sugimoto H, Kaneko T, Inoue S, Takeda S, Nakao A: Simultaneous Doppler measurement of portal venous peak velocity, hepatic arterial peak velocity, and splenic arterial pulsatility index for assessment of hepatic circulation?. HepatoGastroenterology. 2002, 49 (45): 793-797.PubMed Sugimoto H, Kaneko T, Inoue S, Takeda S, Nakao A: Simultaneous Doppler measurement of portal venous peak velocity, hepatic arterial peak velocity, and splenic arterial pulsatility index for assessment of hepatic circulation?. HepatoGastroenterology. 2002, 49 (45): 793-797.PubMed
12.
go back to reference Yan GZ, Duan YY, Ruan LT, Cao TS, Yuan LJ, Yang YL: Noninvasive quantitative testing of liver function using ultrasonography in patients with cirrhosis. Hepatogastroenterology. 2006, 53 (67): 15-20.PubMed Yan GZ, Duan YY, Ruan LT, Cao TS, Yuan LJ, Yang YL: Noninvasive quantitative testing of liver function using ultrasonography in patients with cirrhosis. Hepatogastroenterology. 2006, 53 (67): 15-20.PubMed
13.
go back to reference Chinese Medical Association-Chinese Society of Infectious and Parasitic diseases in conjunction with Chinese Society of Hepatic Disease Chinese Medical Association-Chinese Society of Infectious and Parasitic diseases in conjunction with Chinese Society of Hepatic Disease: Viral hepatitis prevention and treatment programs. Chinese Journal of Hepatology. 2000, 8 (6): 324-329. Chinese Medical Association-Chinese Society of Infectious and Parasitic diseases in conjunction with Chinese Society of Hepatic Disease Chinese Medical Association-Chinese Society of Infectious and Parasitic diseases in conjunction with Chinese Society of Hepatic Disease: Viral hepatitis prevention and treatment programs. Chinese Journal of Hepatology. 2000, 8 (6): 324-329.
14.
go back to reference Zuckerman E, Slobodin G, Sabo E, Yeshurun D, Naschitz JE, Groshar D: Quantitative liver-spleen scan using single photon emission computerized tomography (SPECT) for assessment of hepatic function in cirrhotic patients. J Hepatol. 2003, 39 (3): 326-332. 10.1016/S0168-8278(03)00296-4.CrossRefPubMed Zuckerman E, Slobodin G, Sabo E, Yeshurun D, Naschitz JE, Groshar D: Quantitative liver-spleen scan using single photon emission computerized tomography (SPECT) for assessment of hepatic function in cirrhotic patients. J Hepatol. 2003, 39 (3): 326-332. 10.1016/S0168-8278(03)00296-4.CrossRefPubMed
Metadata
Title
A prospective experimental study of liver fibrosis with ultrasound and its correlation with hepatic reserve function and hemodynamics
Authors
Yi-Lin Yang
Li Di
Yun-You Duan
Xi Liu
Jie Liu
Rui-Jing Yang
Sheng Chen
Li-Jun Yuan
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2012
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-12-168

Other articles of this Issue 1/2012

BMC Gastroenterology 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.